The new omega-3 player is producing algae-based omega-3 eicosapentaenoic acid (EPA).
Aurora Algae Pty. Ltd. (West Perth, Western Australia) has announced several new milestones in its production of algae-based biomass.
On top of Aurora Algae opening a 20-acre demonstration facility in Karratha, Western Australia, the company has also secured an option agreement for more than 1500 acres of land near its demo facility to construct a full-scale commercial manufacturing facility.
Aurora Algae has also received $946,000 AUD in LEEDS grant funding and $750,000 AUD in R&D tax credits from the Australian government in addition to previous LEEDS funding.
These initiatives will enable the company to speed up commercialization of its algae biomass, intended for a variety of applications including vegetarian omega-3 eicosapentaenoic acid (EPA).
Aurora Algae produces algae-based biomass for the nutraceutical, pharmaceutical, aquaculture, and renewable energy markets. The company owns a U.S. processing center in Hayward, California while producing biomass in the “ideal environmental conditions” of Western Australia.
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.